Global Carrier Screening Market to Surpass $7,157.6 Million by 2028, Owing to Rising Prevalence of Genetic Disorders across the Globe

Carrier screening is diagnosis test of genetic disorders or abnormal chromosomal diseases in the carrier person who has inherited one abnormal gene from their parents. The test determines whether a healthy person carries the recessive gene of genetic diseases such as sickle cell disease, cystic fibrosis, and others. Carrier screening test is mostly performed by couples who are parents to be in order to determine the chances of the child’s risk inheriting the genetic disorders from the parents. The demand for carrier screening is increasing over the last few years and thus the manufacturing companies are focusing on developing technologically advanced carrier screening products.

COVID-19 Impact on Carrier Screening Market

The outbreak of COVID-19 across the globe has drastically impacted the global carrier screening market growth. The low growth of the market is majorly owing to the closing down of hospitals and laboratories for non-essential treatments. Besides, people across the carrier screening industry are facing issues related to the less availability of counselors or lab technicians for carrier testing, which is resulting in decreased demand for carrier screening during the pandemic period.

However, reopening of hospitals, laboratories, and the availability of counselors for carrier screening test are the factors expected to boost the carrier screening market growth post-pandemic.

Carrier Screening Market Trends and Developments

The companies operating in the global industry are adopting several growth strategies and business tactics such as partnerships, collaboration, business expansion, and product launches to obtain a leading position in the global industry, which is predicted to drive the global carrier screening market growth in the upcoming years.

For instance, in February 2020, Thermo Fisher Scientific, announced the launch of a new NGS-based test kit in order to enable researchers in the reproductive health field for better analyzing of wide range of key genetic markers. The ‘Ion Torrent CarrierSeq ECS Kit’ consolidates a multi-platform approach to ECS (expanded carrier screening) into a single solution that extends the reproductive health research portfolio of the company, which includes tools for postnatal, prenatal, newborn screening analysis, and invitro fertilization.

In September 2021, NxGen MDx, a leading healthcare company delivering comprehensive genetic testing, created an Early Advantage Panel by taking an innovative approach to genetic carrier screening panel design. Being first of its size, the panel fully incorporates screening recommendation from the U.S. Department of HHS (Health and Human Services). The aim of the company is to focus on improving pregnancy as well as newborn health outcomes for families everywhere.

Forecast Analysis of Global Carrier Screening Market

The global carrier screening market is projected to witness an exponential growth over the forecast period, owing to the technological advancements in carrier screening, such as the rising trend of next-generation sequencing (NGS) technology. Conversely, the lack of awareness among people regarding the benefits of carrier screening is expected to hamper the market growth in the projected timeframe.

The growing prevalence of genetic disorders across the world due to mutation in genes or chromosomes and the growing consciousness among people regarding the benefits of early detection & diagnosis of genetic diseases are the significant factors and carrier screening market trends estimated to bolster the growth of the global market in the coming future. According to a latest report published by Research Dive, the global carrier screening market is expected to garner $7,157.60 million during the forecast period (2021-2028). Regionally, the North America market is estimated to observe dominant growth by 2028, owing to the rising prevalence of advanced screening tests mostly in the U.S. and Canada, and the awareness among people using mass genetic testing programs in the region.

Key Players in the Global Carrier Screening Market

1. Thermo Fisher Scientific Inc.
2. Quest Diagnostics Incorporated,
3. Eurofins Scientific
4. Invitae Corporation
5. Opko Health
6. Fulgent Genetics Inc.
7. Natera Inc.
8. Myriad Genetics,
9. Illumina Inc.,
10. Luminex Corporation.